Prostate Cancer

The addition of six cycles of radium-223 to first-line enzalutamide extended radiographic PFS for men with metastatic castration-resistant prostate cancer, according to results of a randomized phase 3 trial.

National Prostate Cancer Awareness Month is observed every September.

Deleting the CD5 gene from chimeric antigen receptor T cells improved their expansion, durability and tumor-killing capabilities, according to study findings.

Presented results showed patients with periprosthetic joint infection after total hip arthroplasty may have similar rates of mortality compared with those of common cancers such as breast cancer and prostate cancer.

The addition of a pre-ketone supplement to an immunotherapy regimen demonstrated efficacy for treating prostate cancer, according to a study led by researchers at University of Notre Dame.

Men with bone pain at diagnosis of metastatic, hormone-resistant prostate cancer had shorter survival than men without bone pain, according to study results.

In this episode, host Shikha Jain, MD, speaks with Shyam Natarajan, PhD, about machine learning in cancer research and testing, using technological innovation to address disparities in health care trials and more.

Rates of next-generation sequencing have increased for individuals with metastatic prostate cancer or advanced urothelial carcinoma over the past several years, but more than half of these individuals still do not undergo testing.

In this video, Stephen Freedland, MD, discusses the results of the EMBARK study into high-risk, nonmetastatic biochemically recurrent prostate cancer, which he co-presented at ASCO Annual Meeting.

CHICAGO — Drinking more than eight cups of coffee per day significantly increased the risk for prostate cancer among men who smoke tobacco, according to research presented at the annual NUTRITION meeting.